Getein Biotech, Inc (603387.SH) plans to repurchase company shares worth 50 million to 100 million yuan.
Jidansheng Biological (603387.SH) announced that the company plans to use its own funds or self-raised funds to repurchase some of its shares through centralized bidding trading. The repurchased shares will be used to implement an employee stock ownership plan or equity incentives. The total amount of repurchase funds will be no less than 50 million yuan (inclusive) and no more than 100 million yuan (inclusive). The repurchase share price will not exceed 12.51 yuan per share (inclusive).
Getein Biotech, Inc (603387.SH) announced that the company plans to repurchase some of its publicly held shares through centralized bidding trading using its own funds or self-raised funds. The repurchased shares are intended to be used for implementing employee stock ownership plans or equity incentives. The total amount of repurchase funds will be no less than 50 million yuan (inclusive) and no more than 100 million yuan (inclusive). The repurchase price of shares will not exceed 12.51 yuan per share (inclusive).
Related Articles
ChengDu Sheng Nuo Biotec (688117.SH) controlling shareholder intends to increase its stake in the company by 40-50 million yuan.
China Pacific Insurance (02601): Wang Mingchao approved for the qualifications to serve as Vice President.
TENFU (06868) spent approximately 5400 Hong Kong dollars to repurchase 2000 shares on July 3rd.
ChengDu Sheng Nuo Biotec (688117.SH) controlling shareholder intends to increase its stake in the company by 40-50 million yuan.
China Pacific Insurance (02601): Wang Mingchao approved for the qualifications to serve as Vice President.
TENFU (06868) spent approximately 5400 Hong Kong dollars to repurchase 2000 shares on July 3rd.
RECOMMEND
